1
|
Zhou X, Zhou Y, Qian H, Wu F, Liu H, Li X, Li W. Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone. J Dermatol 2023; 50:e354-e356. [PMID: 37341162 DOI: 10.1111/1346-8138.16864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 05/30/2023] [Accepted: 06/02/2023] [Indexed: 06/22/2023]
Affiliation(s)
- Xingli Zhou
- Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China
- Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China
| | - Yuxi Zhou
- Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China
- Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China
| | - Hua Qian
- Department of Laboratory Medicine, Chronic Disease Research Center, Medical College, Dalian University, Dalian, China
| | - Fanglong Wu
- State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - Hongjie Liu
- Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China
- Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China
| | - Xiaoguang Li
- Department of Laboratory Medicine, Chronic Disease Research Center, Medical College, Dalian University, Dalian, China
| | - Wei Li
- Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China
- Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China
| |
Collapse
|
2
|
Xie YH, Wang SH, Li SZ, Zuo YG. Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review. Front Immunol 2022; 13:839094. [PMID: 35317170 PMCID: PMC8934418 DOI: 10.3389/fimmu.2022.839094] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2021] [Accepted: 02/07/2022] [Indexed: 11/13/2022] Open
Abstract
BackgroundA close association between psoriasis and anti-p200 pemphigoid has been demonstrated by numerous studies. However, the clinical characteristics of patients suffering from these two entities have not yet been well-elucidated.ObjectiveThis study aimed to review the case reports and case series, summarizing clinical features and therapeutic strategies in patients suffering from anti-p200 pemphigoid and psoriasis.MethodsA systematic review was conducted by searching PubMed, EMBASE, and Web of Science databases for studies published in English involving patients with psoriasis and anti-p200 pemphigoid on 6 September 2021. All case reports and case series reporting patients diagnosed with anti-p200 pemphigoid and psoriasis were included in this systematic review.ResultsA total of 21 eligible studies comprising 26 anti-p200 pemphigoid patients with preceding psoriasis were included in the qualitative synthesis. The average age at blisters eruption was 62.5 years, and the mean duration between the two entities was 15.6 years. Twenty-four percent of patients developed bullous lesions during UV therapy. Clinical manifestation of bullae and/or vesicles was recorded in all patients, and the trunk (94.7%) was most frequently involved, with only 15.8% reporting mucosal involvement. Epitope spreading was detected by immunoblotting in 33.3% of patients. All the patients reached completed remission during the course of disease, with 36.8% experiencing at least one relapse. Monotherapy of prednisolone was the leading therapeutic approach (n=6, 31.6%) required for disease control, but 5 (83.3%) of them suffered from blister recurrence after tapering or ceasing corticosteroid.ConclusionMost of the clinical aspects of patients with anti-p200 pemphigoid and psoriasis were similar to what was demonstrated in previous articles on anti-p200 pemphigoid. Nevertheless, compared with other anti-p200 pemphigoid cases without psoriasis, a clinical manifestation pattern with more frequent involvement of the trunk and less mucosal involvement was illustrated in those with psoriasis. Generally, monotherapy is sufficient for a complete remission for such patients. However, one or more relapses have been recorded in a considerable portion of patients, especially those prescribed with prednisolone. It reminded us to be more cautious during a tapering of medication.
Collapse
|
3
|
Séméria L, Lamiaux M, Quinchon JF, Modiano P. Anti-p200 pemphigoid mimicking erythema multiforme. JAAD Case Rep 2022; 21:157-159. [PMID: 35242971 PMCID: PMC8866842 DOI: 10.1016/j.jdcr.2022.01.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
- Lucile Séméria
- Department of Dermatology, Amiens-Picardie University Medical Center, Amiens, France
- Correspondence to: Lucile Séméria, Department of Dermatology, Amiens-Picardie University Medical Center, Victor Pauchet, 80054 Amiens Cedex 1, France.
| | - Marie Lamiaux
- Department of Dermatology, Saint-Vincent de Paul Hospital, Lille Catholic University, Lille, France
| | - Jean François Quinchon
- Department of Pathology, Saint-Vincent de Paul Hospital, Lille Catholic University, Lille, France
| | - Philippe Modiano
- Department of Dermatology, Saint-Vincent de Paul Hospital, Lille Catholic University, Lille, France
| |
Collapse
|
4
|
Chai ZT, Lim YL, Busmanis I, Pang SM. Anti-laminin-γ1 pemphigoid in an epitope spreading phenomenon, successfully treated with rituximab. Int J Dermatol 2021; 61:508-510. [PMID: 33998667 DOI: 10.1111/ijd.15656] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/04/2020] [Revised: 02/15/2021] [Accepted: 04/21/2021] [Indexed: 11/28/2022]
Affiliation(s)
- Zi Teng Chai
- Department of Dermatology, Singapore General Hospital, Singapore
| | | | - Inny Busmanis
- Department of Pathology, Singapore General Hospital, Singapore
| | - Shiu Ming Pang
- Department of Dermatology, Singapore General Hospital, Singapore.,Duke-NUS Medical School, Singapore
| |
Collapse
|